Provided by Tiger Trade Technology Pte. Ltd.

ResMed

240.10
-0.2300-0.10%
Post-market: 240.100.00000.00%19:30 EDT
Volume:1.72M
Turnover:413.41M
Market Cap:34.63B
PE:23.02
High:241.71
Open:237.97
Low:236.16
Close:240.33
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.16
T/O Rate:1.20%
Dividend:2.40
Dividend Rate:1.00%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.26
PE(LYR):23.02

Loading ...

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 04

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 01

Sell Winning Stocks at 0% Federal Tax, Reinvest Same Day: Wash Sale Rules Don't Apply

Deep News
·
Jul 31

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 30

NYSE Order Imbalance 75737.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

BofA Adjusts Price Target on ResMed to $320 From $310

MT Newswires Live
·
Jul 24

ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says

MT Newswires Live
·
Jul 22

Resmed Bulls Think Acquisition Timing Looks Awkward

Dow Jones
·
Jul 21

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

MT Newswires Live
·
Jul 17

ResMed downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jul 16

ResMed price target lowered to $220 from $235 at Mizuho

TIPRANKS
·
Jul 15

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 15

Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating

MT Newswires Live
·
Jul 14

Cleveland Medical Devices: Won Favorable Ptab Outcomes in 5 of 6 Resmed Ipr Challenges

THOMSON REUTERS
·
Jul 14

Cleveland Medical Devices: in Four of Five Proceedings, Ptab Determined That Co Had not Established That Challenged Claims were Unpatentable

THOMSON REUTERS
·
Jul 14

Movement Alert|ResMed Falls 5.61% in Regular Trading, Citi Downgrades Rating to Neutral Triggering Sell-Off

Market Focus
·
Jul 13

Movement Alert|ResMed Falls 5.19% in Pre-Market Trading, Citi Downgrades Rating to Neutral

Market Focus
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 13

Resmed Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jul 13